ST. PETERSBURG, Fla., Jan. 23 /PRNewswire-FirstCall/ -- Nutraceutical Clinical Laboratories International, Inc. (OTC Pink Sheets: NCCL), a preservative and nutraceutical products company, today announced that tests conducted during the last 12 months at its Research and Development Facility have demonstrated that one of its preservatives, NuPreserv(TM), extends the shelf life of beverages.
Paul Winniczuk, Director of Beverage Research Development at NCCL stated, "After months of exhaustive testing, we are excited to announce that NuPreserv(TM) can extend the shelf life of beverages, such as orange juice, apple juice, vegetable juices and health and sports drinks. Unlike other preservatives such as sodium benzoate, NuPreserv(TM) does not affect the color, smell or create a bitter aftertaste when used in beverages."
"We believe that the utilization of NuPreserv(TM) into these perishable beverages, and the resulting ability to have the beverages remain fresh in storage, transit and on the grocers' shelves for an extended period of time, will be of great interest to the multi-billion dollar global beverage industry," Winniczuk added. Prior to joining NCCL, Mr. Winniczuk was the Microbiology Manager/QA Specialist for Pasco Beverage Company, a division of Vitality Beverage, the No. 1 U.S. seller of private label juices to grocery store chains.
"The amount of orange juice consumed in the U.S. alone is staggering. This latest development is another example of how committed we are to identifying new applications for NuPreserv(TM) in a select number of high potential industries, and we are very pleased that our product testing has shown that our preservative works with beverages to extend their shelf life," said Gary L. Harrison, Chairman and Chief Executive Officer of NCCL. "We feel this is a positive development for beverage companies looking to realize significant inventory management enhancements, operating efficiencies, reduced delivery scheduling and cost savings."
Harrison added, "In order to maximize the potential of this development, we are in the process of identifying companies to be our exclusive brokerage and marketing representatives for the global beverage industry. This is in line with our philosophy and strategy of outsourcing our sales and marketing needs, not only in the U.S., but globally as well."
NCCL has just completed the first year of supplying NuPreserv(TM) to a major bakery. This segment is continuing to grow as the Company is currently doing extensive testing with several domestic and international bakeries to incorporate NuPreserv(TM) into their products. Additionally, NCCL's Research and Development team continues to test and evaluate the application of its preservative products and processes in other industries and applications, as evidenced by NuPreserv's introduction into the beverage industry.
About Nutraceutical Clinical Laboratories International, Inc.
Incorporated in 1999, Nutraceutical Clinical Laboratories International, Inc. is a company that researches, manufactures and markets preservatives and nutraceutical products. Based in St. Petersburg, Florida, the Company has a Preservative Division and a Medical Division, which includes the wholly owned subsidiary Health Care Direct Services, Inc. (HCD). The Preservative unit focuses on developing, manufacturing and marketing NuPreserv(TM), a preservative that extends the shelf life of food products and beverages. The Medical unit focuses on developing NuPreserv's medical applications and manufacturing and distributing HCD's nutraceutical products to more than 20,000 independent and chain-store pharmacies across the U.S. More information about Nutraceutical Clinical Laboratories International, Inc. is available on the Company's Web site at http://www.nutradata.com.
CAUTIONARY NOTE: Statements contained in this press release that are not historical facts are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from the forward-looking statements contained in this release and which may affect the Company's prospects in general.